REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmavera D.O.O. (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pharmavera D.O.O. Profile Updated: September 30, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Pharmavera D.O.O. is an enterprise based in Serbia. Its main office is in Belgrade. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on March 15, 2013. It currently has a total number of 6 (2024) employees. The latest financial highlights indicate a net sales revenue drop of 4.93% in 2025. During that time, Pharmavera D.O.O.’s total assets grew by 18.1%. In, 2025, the company’s net profit margin decreased by 6.4%.

Headquarters
Lazara Mamuzica 26 A
Belgrade; Belgrade;

Contact Details: Purchase the Pharmavera D.O.O. report to view the information.

Basic Information
Total Employees:
Purchase the Pharmavera D.O.O. report to view the information.
Financial Auditors:
Purchase the Pharmavera D.O.O. report to view the information.
Incorporation Date:
March 15, 2013
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Pharmavera D.O.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
-4.93%▼
Total Operating Revenue
3.68%▲
Operating Profit
-67.84%▼
EBITDA
-67.29%▼
Net Profit/Loss for the Period
-74.28%▼
Total Assets
18.1%▲
Total Equity
-7.6%▼
Operating Profit Margin
-7.66%▼
Net Profit Margin
-6.4%▼
Return on Equity (ROE)
-17.41%▼
Debt / Equity
26.1%▲
Quick Ratio
-0.48%▼
Cash Ratio
-1.1%▼

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?